Lv41
550 积分 2025-01-12 加入
Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18)
1小时前
已完结
Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial
2天前
已完结
Utility of CA125 KELIM in predicting benefit from hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer: pooled analysis of KGOG3042 and KOV-HIPEC-01
2天前
求助中
LBA38 Phase III study of camrelizumab plus famitinib versus platinum-based chemotherapy as first-line therapy for recurrent or metastatic cervical cancer
18天前
已完结
LB014/#1671 Cadonilimab plus chemotherapy ± bevacizumab as 1L treatment for persistent, recurrent, or metastatic cervical cancer (R/M CC): a randomized, double-blind, placebo-controlled phase 3 study (Compassion-16)
19天前
已关闭
Gynecologic cancers in 2025: a year in review
20天前
已关闭
Antibody-Drug Conjugates in Gynecologic Oncology: Advances, Challenges, and Future Directions
20天前
已完结
Antibody-drug conjugates in gynecologic oncology: an overview of regulatory approvals and future directions
7个月前
已关闭
Major complications and surgical reintervention after ultrasound-guided transcervical radiofrequency ablation of uterine fibroids : A 10-year Experience
10个月前
已完结
The Application of Berberine in Fibrosis and the Related Diseases
11个月前
已完结
皖公网安备34019202002308
